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INTRODUCTION 
              Prostate  cancer  is currently the  second most common cancer  in  men  
and  is  a  major  healthcare  concern  as  it  cause  significant  morbidity  and  
mortality.  As  location  of  prostate  is  not  favorable  for  direct  examination ,  
digital  rectal  examination  and  prostate  specific  antigen  (PSA)  levels  were  
used  historically  to  evaluate  prostate  cancer . This method of examination 
was inadequate.  Introduction  of  ultrasound  has  provided  a  new  means  to  
evaluate  prostate.  A biopsy of prostate is required for confirming the  
diagnosis  of  prostate  cancer  in  patients  who have  elevated  levels of  
prostate  specific  antigen (PSA)  and  abnormal findings on digital  rectal  
examination. 
 
              Currently Transrectal ultrasonography  (TRUS)  is  the  most 
commonly  used   modality  of  choice  for  imaging  the  prostate gland. 
Ultrasound visualized cancers usually appear hypoechoic relative to normal 
prostatic tissue. Most of hypoechoic foci which are detected by TRUS are not 
malignant; therefore, both its sensitivity and specificity are low. TRUS can 
provide a means of image guidance for multi core biopsy of prostate. 
 
              Prostate cancer is usually a stiff lesion. A technique which is able to 
map the elasticity of prostate can be useful in locating and detecting cancer 
areas within the prostate gland. The tissue stiffness information provided by 
  
 
 
ultrasound elastography should improve the prostate cancer detection and can 
provide guidance for biopsy. 
 
              Our prospective study aims at determining the role of transrectal 
ultrasonography in the evaluation of prostate cancer and usefulness of 
elastography to localize and target the biopsy from suspicious lesions in a 
clinical setting with pathological diagnosis as the reference standard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aims and objectives 
 
 
 
  
 
 
AIMS AND OBJECTIVES 
 
 
PRIMARY 
 
• To assess the role of transrectal ultrasound in accurately identifying 
malignant lesions in prostate. 
• To assess the role of strain elastography in prostate cancer in terms 
of lesion identification and biopsy guidance. 
 
SECONDARY 
 
• To stratify the sonoelastographic findings on the basis of grading 
systems and its correlation with biopsy findings. 
• To correlate grey scale and sonoelastographic findings with 
histopathology. 
 
 
 
 
 
 
  
 
 
STUDY DESIGN:  Prospective study 
DATA PLAN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLINICAL EVALUATION 
TRANSRECTAL B-MODE 
ULTRASONOGRAPHY 
DISEASE CATEGORISATION 
TRANSRECTAL REAL TIME STRAIN 
ELASTOGRAPHY 
ELASTOGRAPHIC GRADING 
HISTOPATHOLOGICAL 
CORRELATION 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and methods 
  
 
 
 
MATERIALS AND METHODS 
 
              30 patients referred to our department with elevated PSA levels (>4 
ng/ml) and abnormal findings on DRE were included in the study. The duration 
of study was from December 2014 to September 2016. Informed consent was 
obtained from all the patients and possible complications of biopsy were 
explained to all patients. Before the procedure, prophylactic antibiotics were 
given. All patients underwent transrectal ultrasonography, transrectal real time 
strain elastography as well as biopsy taking in the same sitting. Final diagnosis 
was confirmed with histopathological examination. 
 
              Transrectal ultrasonography of prostate was done with a SIEMENS 
ACUSON S3000 using an endocavitary transducer with 9-4 MHz range and 
174 degree field of vision capable of user selectable multi hertz imaging. 
Xylocaine gel was applied over a probe cover applied onto the probe. All 
patients were examined in the left lateral decubitus position because it was well 
tolerated. Prostate was imaged in both axial and sagittal planes with assessment 
of volume, echogenicity, surface, calcification, vascularity and the presence of 
nodules. Each nodule was assessed for size, location in the gland, morphology, 
echogenicity, margin, and extent. 
 
              Ultrasound Elastography was performed with SIEMENS ACUSON 
S3000 using the same probe used for transrectal ultrasonography at the same 
  
 
 
time as the Ultrasound examination. Transrectal real-time strain elastography 
of prostate was done. The probe is placed over the region such that the lesion is 
in the centre of the image. Elastogram were obtained by a slight compression 
and decompression of the prostate. At least a 5 mm thickness of normal 
adjacent tissue was included, to assess the lesion stiffness in relation with the 
average elasticity of the surrounding tissue. The target lesions were graded 
using a scoring system which was proposed by Kamoi et al 
[13]
. 
 
              Sampling of the prostate was performed either in the sagittal or in the 
axial plane. Biopsies were taken using a biopsy gun (18 G × 25 cm). Extended 
core biopsy protocol (12 cores) was used. After biopsy samples were obtained, 
they were persevered in 38% formaldehyde solution and were sent to the 
histopathology department for analysis. Targeted biopsy specimens obtained by 
TRUS and elastography guidance are sent to histopathology department in two 
separate containers if lesions were identified. 
 
              The grade (degree of aggressiveness) of prostate cancer was evaluated 
on the basis of the Gleason score. The pathologist examined two tissue samples 
taken from different areas of the prostate and assigned each sample a score 
between 1 and 5. The sum of the two maximum scores was the Gleason score. 
Few minor complications were observed after the procedure and were 
controlled. 
 
  
 
 
FIGURE 1: ELASTOGRAPHIC GRADES PROPOSED BY KAMOI ET 
AL. 
[13]
. 
Grade1 
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Grade3     
 
  
 
 
Grade4    
             
 
Grade5 
 
 
Grade 1 – Normal - homogeneous strain 
Grade 2 – Probably normal - symmetric heterogeneous strain 
Grade 3 - Indeterminate –asymmetric focal stiff lesion which is not related to 
any hypoechoic area 
Grade 4 – Probably carcinoma - hypoechoic lesion with stiffness in the center 
and strain at the periphery of the lesion 
Grade 5 - Definitely carcinoma – hypoechoic lesion with stiffness in the entire 
lesion and in the surrounding area 
  
 
 
INCLUSION CRITERIA: 
 
• Elevated PSA level 
• Abnormal findings on digital rectal examination 
• Negative biopsies in the past, but still continuing high suspicion for 
prostate cancer 
 
EXCLUSION CRITERIA: 
 
• Severe bleeding diatheses 
• Inflammatory bowel disease 
• Surgical absence of rectum, ileo-anal pouch 
• Patients on anticoagulation with international normalised ratio (INR) 
above 1.3 
• Patients who refuse to give consent/not willing for Biopsy 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review of the literature 
 
 
  
 
 
REVIEW OF LITERATURE 
ANATOMY 
              The prostate gland is a fibromuscular gland which is shaped like an 
upside down pyramid and it surrounds the prostatic urethra from the bladder 
base to the urogenital diaphragm. It has an outer fibromuscular band which 
forms a false capsule. The prostate makes about 30% of the volume of seminal 
fluid.  Prostate gland constitutes an apex which lies inferiorly sitting on the 
urogenital diaphragm, a base in relation to bladder, an anterior wall which is 
separated from the pubic symphysis by the retropubic fatty space of Retzius, a 
posterior wall related to the rectum behind and two inferolateral walls related to 
the muscles of the pelvic side wall and the anterior part of levator ani on either 
side. 
 
              Mature prostate gland is divided into glandular and non-glandular 
tissue. Glandular tissue is subdivided into three zones- central, transition and 
peripheral. Central zone contains 25% glandular tissue and is a wedge shaped 
area which forms the base of the prostate and surrounds ejaculary ducts, 
posterior to prostatic urethra.  Transition zone containing 5% glandular tissue 
lies around distal part of prostatic urethra at the level of the ejaculatory ducts 
and verumontanum. Peripheral zone contains about 70% glandular tissue is 
cup-shaped and encloses central and transition zones. A fibrous tissue separates 
peripheral zone from central and transition zones. The anterior fibromuscular 
stroma makes up the non-glandular tissue. 
The normal prostate gland volume in the adult is approximately 20 cm
3
. 
  
 
 
 
FIGURE 2: ZONAL ANATOMY OF PROSTATE 
 
BLOOD SUPPLY AND LYMPHATIC DRAINAGE 
 
• Arterial supply:· Prostate is supplied by the prostatic arteries which are 
branches of prostaticovesical arteries arising from the internal iliac arteries on 
each side. The prostatic artery gives rise to urethral and capsular arteries. The 
urethral artery supplies about one-third of the prostate while the capsular 
branches supply the remainder of the gland. 
 
• Venous drainage:· via the periprostatic plexus to the internal iliac veins and 
also the vertebral venous plexus. 
 
• Lymphatic drainage:· into internal iliac and obturator lymph nodes. 
 
 
  
 
 
IMAGING OF THE PROSTATE GLAND 
 
ULTRASOUND 
 
              The prostate can be imaged sonographically by transabdominal, 
transperineal, transurethral and transrectal approach. The suprapubic approach 
allows for gross evaluation of the prostate size but does not offer images of 
sufficient quality to visualize the zonal anatomy. Transperineal method is 
compromised by beam scattering but may be useful in patients following 
abdominoperineal resection. Transurethral approach using 7.5 to 10 MHz 
transducer affords enhanced visualization of the transitional zone but has poor 
resolution of the peripheral zone and is an invasive technique. 
 
              Transrectal ultrasonography (TRUS) is currently the preferred method 
because of its ability to demonstrate the zonal anatomy, the ejaculatory ducts 
and seminal vesicles. The most commonly used commercially available probes 
(with a transducer frequency ranging from 5 to 8 MHz) fire from the end and 
the longitudinal and axial scans are obtained by rotating the transducer through 
a 180° axis. Other probe designs include 360° radial scanners paired with end 
viewing probes for a sagittal image and paired side viewing axial and sagittal 
probes. The advantages of end-viewing probe designs include patient 
convenience, ease of use, and biopsy capability at the time of the diagnostic 
  
 
 
              On transrectal ultrasound prostate usually has an homogenous and 
uniform echo pattern. Central and peripheral zones cannot be differentiated by 
ultrasound. These two zones are seen in a normal person as an isoechoic and 
homeogenous area in the posterior section of the prostate.  Other structures are 
defined hypo or hyperechoic by comparing with the echo pattern of these two 
zones. The transition zone constitutes a small percentage of prostate in a young 
man and is difficult for imaging.  Transition zone will be expanded in older 
individuals with benign prostatic hyperplasia and compresses its surrounding 
fibromuscular band of tissue giving rise to the surgical capsule of the prostate. 
This capsule is used as a landmark of zonal demarcation in ultrasound. The 
transition zone is relatively hypoechoic compared to other zones. The 
peripheral zone is usually the most reflective, although it may be 
indistinguishable from the rest of the gland. The urethra is seen as a central 
anechoic structure which is surrounded by a hypoechoic area comprising of 
periurethral glands, smooth muscle and the transition zone. The seminal 
vesicles can be seen as sacculated structures located above and lateral to the 
base of the prostate gland. The ejaculatory ducts can be identified sometimes as 
hypoechoic beak projecting into the central zone. The neurovascular bundles 
can be identified posterolaterally in the triangular fat filled echogenic space 
between the prostate and the seminal vesicles. 
 
 
 
  
 
 
FIGURE 3: TRANRECTAL ULTRASONOGRAPHY IMAGE 
SHOWING ZONAL ANATOMY OF PROSTATE 
 
 
ELASTOGRAPHY 
 
              Elastography is a technique used to assess the stiffness of a lesion. 
Elastogram is a colour coded image obtained by applying pressure to desired 
area and depicts the relative tissue stiffness. The region of interest (ROI) is 
chosen after the initial B-mode Ultrasonography. In strain elastography of the 
prostate, mechanical stress is induced to analyse tissue deformation in a region. 
A quality index helps to achieve an appropriate pressure and speed. Soft lesions 
have an increased strain and stiff lesions shows a reduced strain. 
 
              The normal prostate will display a homogenous strain on elastography. 
Heterogeneous strain may be noted in large prostate and in cases of benign 
prostatic hyperplasia. Usually the Central, periurethral tissue will appears 
stiffer compared to other areas in normal prostate. Elastography helps to 
Transition  
zone 
Central zone 
Peripheral 
zone 
  
 
 
characterize the abnormal regions detected by B-mode imaging and also can 
detect lesions which are not seen by other technique. Elastography also can be 
used for targeting the lesions for biopsy. Hard lesions on elastography which 
appears hypoechoic on B-mode are considered highly suspicious for 
malignancy. 
 
COMPUTED TOMOGRAPHY (CT) 
 
              The prostate appears as homogeneous dense structure on computed 
tomography. Though CT provides a rough assessment of prostatic size and 
contour, it is not possible to differentiate normal from hyperplastic gland or 
detect the cancer when it is confined within the prostate gland. 
 
MAGNETIC RESONANCE IMAGING (MRI) 
 
              MRI allows detailed visualization of normal zonal anatomy of the 
prostate, the prostatic capsule, periprostatic structures and also pelvic lymph 
nodes 
              On T1W images the zonal anatomy is not very clear and the gland is 
of uniform low signal intensity. T1W images are useful for detection of 
hemorrhage (post-biopsy) and to differentiate cyst from an abscess. Internal 
architecture of the prostate is best appreciated on T2W image. The peripheral 
zone has high-signal intensity while the central and transitional zones have 
  
 
 
relatively low-signal intensity. However, central and transitional zones cannot 
be differentiated from each other, and both together are termed as central gland. 
In young men, the central gland predominantly consists of central zone. In 
older men, with prostatic hyperplasia most of the central gland consists of 
transitional zone. The anterior fibromuscular stroma is dark on all pulse 
sequences. Seminal vesicle fluid appears bright on T2W image while the walls 
are hypointense. The periprostatic fat is hyperintense on both T1WI and T2WI 
and allows easy assessment of periprostatic spread of growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
SONOLOGICAL FEATURES OF COMMON DISEASES OF 
PROSTATE 
 
BENIGN PROSTATIC HYPERPLASIA (BPH) 
 
              Prostate gland enlargement is common in older men; however the 
gland size does not always correlate with symptoms of prostatism. BPH starts 
in the form of nodules in the transition zone which enlarge in size and number, 
eventually impinging on the adjacent central and peripheral zones. 
 
              The sonographic appearance of benign prostatic hyperplasia is varied 
and depends on the histopathologic changes. Diffuse enlargement or distinct 
nodules can be present in the transition zone, the periurethral glandular tissue, 
or in both. The typical sonographic feature of BPH is enlargement of the inner 
gland, which appears relatively hypoechoic to the peripheral zone. The border 
between central and peripheral gland which is indistinct in young men, 
becomes more distinct due to presence of BPH. The echo pattern of central 
gland depends on the admixture of glandular and stromal elements. Nodules 
may be fibroblastic, fibromuscular, muscular, hyperadenomatous, and 
fibroadenomatous. Depending on the combination; the nodules may appear 
either isoechoic, hyperechoic or hypoechoic. Calcifications may also be seen in 
the central zone. 
  
 
 
              Because the growth of the gland is primarily anterior, the volume or 
weight cannot be estimated well by digital palpation. Prostatic ultrasound 
provides an accurate and reproducible method to determine the prostatic 
volume and the effect of the hyperplasia on the anterior urethra that correlates 
with the symptoms of prostatism. 
 
PROSTATE CANCER 
 
              Prostate cancer is the one of the most common cancer and it ranks as 
the second common cause of cancer death in men. Adenocarcinoma is the most 
common histological type, encountered in approximately 95 percent of 
patients. Around 70 percent of the prostatic cancer originates in the peripheral 
zone, 10 to 20 percent in the transitional zone, and 5 to 10 percent in the central 
zone. Multicentricity of the tumor is quite common. Approximately 30-46% 
men above 50 years of age may harbor a cancer focus but less than 20% of 
those develop clinical disease which is largely related to variability in 
aggressiveness. Imaging has little role in early detection of cancer but has a 
vital part in local and distant staging of the disease. Diagnostic tests for local 
staging must aim to differentiate organ confined disease from locally invasive 
disease extending beyond capsule (ECS) into periprostatic fat, lymphatics and 
vessels (stage 3) or adjacent organs (stage 4). Due to proximity, invasion of 
seminal vesicles and bladder base superiorly, membranous urethra distally and 
rarely rectum posteriorly should be looked for. Patients with metastatic disease 
  
 
 
fare worst and a lymph nodal and distant metastasis work-up is part of routine 
evaluation. 
 
Prostate adenocarcinoma— TNM staging classification 
 
T1 Clinical localized: Tumor not palpable on digital rectal examination 
T1a Focal tumor (< 5% of resected tissue on TURP) and low grade 
T1b Diffuse tumor (> 5% of resected tissue on TURP) and high grade 
T2 Clinically localized: Tumor palpable 
T2a Tumor involves < 0.5 lobe 
T2b Tumor involves > 0.5 lobe 
T2c Tumor involves both lobes 
T3 Locally invasive beyond prostatic capsule: Tumor palpable 
T3a Unilateral extracapsular extension 
T3b Bilateral extracapsular extension 
T3c Seminal vesicle invasion 
T4 Invades adjacent tissue (e.g. bladder, rectum, levator ani muscles) 
N/M Metastatic disease 
N 1-4 Metastases to lymph nodes 
M 1- Distant metastases 
 
              Confined disease (T2) is treated with surgery or radiotherapy while 
extracapsular spread or seminal vesicle invasion (T3) is treated with radiation 
  
 
 
and /or hormonal therapy. The Gleason scoring system which is based on the 
architectural growth patterns of prostatic adenocarcinoma was first described in 
1966. The histological patterns are grouped into five grades, which are viewed 
as a continuum. It was found that tumors behaved more like the “average” 
grade rather than the highest grade present; therefore, Gleason developed a 
“score” based on the grade of the predominant pattern added to the grade of the 
second most prevalent pattern. Clinical staging with digital rectal examination 
(DRE), serum PSA and biopsy tumor grade (Gleason score) remains the 
standard of practice though it under stages ECS in up to 30-60% cases. 
However, definitive therapy also takes into consideration patient’s life 
expectancy, his general health, tumor prognostic factors and presence of 
metastasis. Particularly, patients at increased risk for metastatic disease 
(Gleason score 8-10, serum PSA >20 ng/ml or clinical stage T3-4) must 
undergo imaging work-up before definitive therapy.  On the other hand, 
patients with intermediate risk (Gleason score 5-7 and PSA 10-20) need further 
elucidation of prognostic factors by newer techniques estimating metabolic 
information, i.e. spectroscopy, angiogenesis by color Doppler and perfusion 
imaging and cellularity, i.e. diffusion imaging. 
 
              Transrectal ultrasonography alone has limited role in identifying 
prostatic cancer because of the variable ultrasonographical appearance of 
prostatic tumors, frequent multifocality of tumor within the prostate, the poor 
specificity of focal ultrasonographic abnormalities, and the substantial 
  
 
 
percentage of isoechoic prostate tumors which cannot be differentiated from 
adjacent benign tissues with imaging. Color Doppler and power Doppler has 
been added to TRUS in an attempt to increase the sensitivity and specificity of 
prostate ultrasound and ultrasound-guided biopsy. Preliminary reports suggest 
that increased vascularity in a prostatic lesion correlates with high grade cancer 
and can suggest the lesion to be biopsied. 
 
The indications for TRUS in patients with known or suspected prostate cancer 
are: 
o Evaluation of the patient with an abnormal digital rectal examination 
o Evaluation of the patient with abnormal laboratory test results indicative 
of prostate cancer, including PSA, acid phosphatase, or other evidence 
of metastatic disease 
o Guidance for biopsy 
o Monitoring response to treatment for prostate cancer. 
 
              Against the background of normal peripheral zone glandular tissue, 
small prostatic cancer usually appears hypoechoic because of closely packed 
cells in the tumor nodule. Larger tumors may appear isoechoic or hyperechoic. 
This appearance may be caused by a desmoplastic response of surrounding 
normal tissue or due to infiltration of the neoplasm into a background of benign 
prostatic hyperplasia. When an isoechoic tumor is present, it can be detected by 
presence of secondary signs including glandular asymmetry and capsular 
  
 
 
bulging. When the cancer totally replaces an entire zone or the entire gland, its 
identification becomes difficult. Such diffuse lesions must be identified based 
on the expected echogenicity of the area examined rather than its relation to 
surrounding structures. Ultrasound features which strongly suggest tumour are 
presence of hypoechoic nodule in the peripheral zone, diffuse 
hypoechogenicity in the peripheral zone, nodule with surrounding altered 
echogenicity and a hypervascular hypoechoic nodule in the peripheral zone.  
Periprostatic extension may be suspected when there is disruption of capsule 
echogenicity, and irregularity or bulging of the capsular margin. Seminal 
vesicle extension can be defined sonographically by enlargement, cystic 
dilatation, asymmetry, anterior displacement, hyperechogenicity, and loss of 
the seminal vesicle beak. A comparison from the other normal side can be 
helpful. Because of the high frequency transducers and thus limited depth of 
penetration, TRUS does not permit pelvic lymph node assessment. Sensitivity 
of TRUS for local extension into the capsule or seminal vesicles in different 
studies range from as high as 90 percent and as low as 40 to 60 percent and 
specificities for invasion range from 46 to 90 percent, depending on the size of 
primary tumor. In patients with BPH the mixed echo pattern can mask central 
gland and anterior tumours. Some areas in prostate have a recognized higher 
incidence for tumor like posterolateral horns, base and the apex. 
 
              Newer developments in TRUS equipment in the past decade include 
the use of higher frequencies, harmonic imaging, power Doppler, elastography, 
  
 
 
contrast harmonic, broad bandwidth technologies and pulse inversion imaging. 
These new technologies may enhance the detection of subtle abnormalities 
within the prostate on ultrasonography. Contrast enhanced ultrasonography can 
improve the detection of subtle changes in prostatic echotexture by highlighting 
microvasculature changes. 
 
PROSTATITIS AND PROSTATIC ABSCESS 
 
              Acute focal or diffuse suppurative inflammation of the prostate (acute 
prostatitis) occurs most commonly due to ascent of bacteria from the urethra, 
less often by descent from the upper urinary tract or bladder, and occasionally 
by lymphogenous or hematogenous spread from a distant focus of infection. 
The common pathogens are those which cause urinary tract infection like 
E.coli, Klebsiella, Proteus, Pseudomonas, etc. Chronic prostatitis is caused in 
much the same way and by the same bacterial pathogens as the acute 
prostatitis; however, it may be associated with certain abacterial pathogens 
such as Chlamydia or Mycoplasma organisms. 
 
              In acute prostatitis, generally the glands are hypoechoic. Color 
Doppler shows a very vascular focus in areas of prostatitis, mimicking 
carcinoma. The development of an anechoic mass with or without internal 
echoes suggests the development of an abscess, which on color Doppler shows 
a highly vascular wall. The abscess cavity may also contain air due to gas 
producing organisms. 
  
 
 
 
              Sonographic findings of chronic prostatitis includes focal masses of 
varying echogenicity, irregularity or thickening of capsule, calcifications in 
ejaculatory duct,  and irregularity of periurethral glands. In addition dilatation 
of periprostatic veins and distention of seminal vesicles may be seen. Chronic 
granulomatous prostatitis can mimic sonographic features of prostatic 
carcinoma. Solitary or multiple diffuse large or small hypoechoic zones may be 
seen. 
 
PROSTATIC CYSTS 
 
              Midline prostatic cysts can be Müllerian duct cysts or utricle cysts. 
Müllerian duct cysts do not contain sperms and can cause infertility due to 
compression of the ejaculatory ducts. Utricle cysts contain sperms but unlike 
former do not extend beyond prostate. The paramidline cysts are Wolffian 
cysts, seminal vesicle cysts or ejaculatory duct cysts which contain sperms. 
Associated Wolffian duct anomalies, i.e. renal anomalies may be seen in these 
patients. Peripheral cysts are acquired retention cysts and may be associated 
with BPH. Cowper’s gland cysts are also acquired cysts associated with 
urogenital diaphragm. 
 
              Cystic lesions appear smooth walled and hypoechoic on USG unless 
complicated by infection or hemorrhage. 
 
  
 
 
REVIEW OF LITERATURE 
 
              Transrectal ultrasound was firstly described by Watanabe et al.
[1] 
(1967). A 3.5 MHz transducer was used by them which provided the first 
clinically useful images of prostate. 
 
              Ultrasound-guided systematic sextant biopsy was reported initially by 
Hodge et al.
[2] 
(1989). In their study on 136 men with abnormal digital rectal 
examination findings, biopsies were taken parasaggitally from the apex, middle 
and base of the prostate gland from each side, in addition to hypoechoic lesions 
detected on ultrasound. Prostate cancer was identified in 9% of cases by 
systematic sextant biopsy and in 5% of cases by directed biopsy. 
 
              Eskew et al.
[3] 
(1997) firstly introduced the systematic extended 
biopsy technique. In this technique the sextant biopsy method was combined 
with additional biopsy cores. They performed a systematic five-region biopsy 
in which 2 additional cores from the far lateral lobe on each side and 3 from the 
middle of the gland is taken in addition to conventional sextant biopsies. When 
the prostate was more than 50 cc, they took one additional core per region. In 
this study they found that in 35% of patients diagnosed with prostate cancer, 
cancer was detected in the extra five biopsies sites and not in the sextant 
regions. 12% of those tumors were in the central zone and 88% were located in 
the far lateral zones. 
  
 
 
              Levine et al.
 [4]
 (1999) conducted a study on 137 men who were 
subjected to two independent consecutive sets of sextant biopsies in the same 
sitting.  Their study showed that there was an increase in detection rate of 
prostatic cancer from 21% by doing sextant biopsy alone to 31% with the use 
of additional six biopsies. 
 
              Presti et al.
 [5]
 (2000) conducted a study on 483 men with PSA > 4 ng 
/mL or abnormal DRE in which they took two extra cores of biopsies from the 
base and mid gland laterally on each side in addition to the standard sextant 
technique. On analysis they found that sextant technique missed 20% of 
cancers. This 10-core biopsy scheme missed eight cancers which were detected 
by targeting the lesions or transition zone biopsies and a detection rate of 96% 
was achieved. 
 
              Babaian et al. 
[6]
 (2000) investigated an 11-core biopsy protocol 
which included the anterior lateral peripheral zone on each side (anterior horn), 
transition zones which are anterior and next to the urethra on each side, and one 
mid-gland in addition to the traditional sextant sites. They found a 33% 
increase in detection of prostate cancer by using these additional zones. 
 
              Cochlin et al.
 [7] 
(2002) introduced real time elastography for detecting 
prostate cancer in biopsy specimens. In their study on 100 patients in addition 
to sextant biopsy, additional targetted biopsies of suspicious sites were also 
  
 
 
taken and anlaysed with histopathology results. They found that real time 
elastography had a sensitivity of 51% and specificity of 83% in detecting 
prostate carcinoma. 
 
              Konig et al 
[8]
 (2005) described the role of elastography to guide 
prostate biopsy. In their study on 404 men with increased PSA and/or abnormal 
digital rectal examination, a systemic sextant biopsy and elastographic guided 
biopsy was performed after imaging with conventional B-mode ultrasound and 
real-time elastography. Prostate carcinoma was detected in 37.4% of patients. 
On analysis they found that 84.1% of cancers were detected by elastography 
guided biopsies but only 64.2% of cancers were detected by conventional 
ultrasound guided biopsies. A stiff lesion which is reproducible after tilting the 
probe with diameter of atleast 5 mm was the diagnostic criteria for prostate 
carcinoma on elastography based on their study. 
 
              Pallwein et al 
[9] 
(2007) assessed the utility of real-time elastography 
in detecting prostate cancer in biopsy proven prostate carcinoma patients who 
were scheduled for radical prostatectomy. They evaluated 15 patients with real 
time elastography and considered hard lesions on elastography with a diameter 
of 5mm or more as malignant. They assessed location and size of cancer in real 
time elastography alone and then patients underwent radical prostatectomy. 
When they analysed real time elastography findings with post operative 
  
 
 
histopathological findings, they found that real time elastography had a 
sensitivity of 80% in detecting carcinoma prostate. 
              Nelson et al 
[10] 
(2007) evaluated the role of gray scale ultrasound, 
color Doppler and elastographic imaging for detecting prostate cancer and 
distribution of Gleason scores. Abnormal areas which were detected by gray 
scale ultrasonography, elastography and color Doppler were targetted in 
addition to laterally directed sextant biopsies. They found that targeted biopsy 
cores based on gray scale, elastographic imaging and color Doppler returned 
more positive biopsy results as compared with systematic biopsy cores. They 
also found that lesions with gleason score of 8 to 10 shows abnormal color flow 
on doppler whereas lower grade lesions did not demonstrate any significant 
abnormality on colour doppler. In their study there was a positive association 
between elastography and lesions with Gleason scores of 5 to 10. 
 
              Sumura et al 
[11] 
(2007) evaluated detection of prostate cancer with 
real-time elastography and compared it with pathologic analysis after radical 
prostatectomy. They conducted a study on 17 patients who underwent real time 
elastography along with transrectal ultrasonography, Colour Doppler 
ultrasonography, magnetic resonance imaging and digital rectal examination 
prior to radical prostatectomy. They found that real-time elastography had a 
higher cancer detection rate when compared to other modalities, especially for 
tumors with larger size and a higher Gleason score. 
 
  
 
 
              Pallwein et al 
[12] 
(2008) assessed the value of sonoelastography in 
detecting prostate cancer on comparing with systematic biopsy findings. They 
evaluated the tissue elasticity of the peripheral zone and compared it with 
systematic 10-core biopsy results in 492 patients. Sonoelastography had a 
sensitivity of 86% and specificity of 72% according to their study.  There was a 
good correlation between elastography findings and systematic biopsy results 
according to their study. 
 
              Kamoi et al 
[13] 
(2008) evaluated the diagnostic performance of 
transrectal real time strain elastography for differentiation of malignant lesions 
of prostate from benign ones and compared with histopathological results 
obtained by ultrasound guided biopsy. Their study consisted of 107 men 
referred with serum prostate specific antigen level of more than 4 ng/mL and/or 
abnormal findings on digital rectal examination. All of their patients underwent 
conventional B-mode transrectal ultrasonography, power Doppler 
ultrasonography, transrectal real-time elastography and were subjected to 
transperineal systematic 8-cores biopsies. In addition they took up to four cores 
of biopsy by transrectal ultrasonography, power Doppler ultrasonography, 
transrectal real-time elastography guidance. They adopted a new five-point 
subjective scale for transrectal real-time elastography detected lesions by 
taking in account of the distribution and degree of stiffness in relation to the 
hypoechoic areas which were simultaneously displayed grey scale images. 
These findings were compared with histopathological results. They found that 
  
 
 
transrectal real time elastography had a sensitivity of 68%, specificity of 81% 
and an accuracy of 76% for detecting prostate carcinoma whereas transrectal 
ultrasonography had a sensitivity of 50% only. They also found that transrectal 
real-time elastography has comparable results with power Doppler 
ultrasonography which had 70% sensitivity, 75% specificity and 73% accuracy. 
 
              Salomon et al 
[14] 
(2008) evaluated the role of real time Elastography 
in detection of Prostate Cancer in comparison to Step Section histopathological 
analysis after radical prostatectomy. They studied 109 patients who were 
biopsy proven for prostatic cancer. All patients undergone real time 
elastography before radical prostatectomy and its findings were correlated with 
whole-mount specimen obtained after radical prostatectomy. On analysis they 
found elastography had a sensitivity of 75.4% and specificity of 76.6% for 
prostate cancer detection. Positive predictive value, negative predictive value 
and accuracy for real time elastography according to their study were 87.8%, 
59%, and 76%, respectively. They came to the conclusion that real time 
Elastography has a good accuracy for detecting foci of cancer within the 
prostate gland and thereby increasing ultrasound based prostate cancer 
detection. 
              Ferrari et al 
[15] 
(2009) assessed the diagnostic efficacy of transrectal 
real time elastography on comparing with transrectal B-mode ultrasonography 
for the detection of tumors in suspicious patients. A 10-core systematic biopsy 
along with extra targeted biopsies from abnormal areas detected by transrectal 
  
 
 
ultrasound and real time elastography were taken in 84 patients. After 
analysing they found that real time elastography is more accurate than B-mode 
ultrasound in evaluating the peripheral zones of the prostate and also help in 
the selecting the appropriate sites for biopsy. 
 
              Aigner et al 
[16] 
(2010) evaluated the rate of  prostate cancer detection 
by real time elastography targeted biopsy in men with total prostate specific 
antigen level between 1.25 to 4.00 ng/ml. In their study on 94 men with 
prostate specific antigen range of 1.30 to 4.00ng/ml, they evaluated peripheral 
zone tissue elasticity using real-time elastography and hard areas were defined 
suspicious for malignancy and were targeted for biopsy with a maximum of 5 
cores. This was followed with a 10-core systematic biopsy in all patients and 
they compared cancer detection rate by both methods. On analysis they found 
real-time elastography had 74% sensitivity, 60% specificity, 39% Positive 
Predictive Value and 93% Negative Predictive Value by patient. They also 
found that real-time elastography had a 4.7-fold higher cancer detection rate 
per core than for systematic biopsy. 
 
              Giurgiu et al 
[17] 
(2011) conducted a study on 65 men to assess 
whether transrectal sonoelastography can improve prostate cancer detection 
either alone or in association with other ultrasound methods. All patients were 
subjected to transrectal ultrasonography, Doppler ultrasonography, and 
sonoelastography in the same sitting and were followed with systematic 
  
 
 
prostate biopsies consisting of 6-12 cores. When they correlated histopathology 
and imaging findings, sonoelastography had a sensitivity of 67.85%, specificity 
of 62.16%, positive predictive value of 57.57% and negative predictive value 
of 71.85%. They also found that diagnostic reliability of sonoelastography was 
higher for a certain subgroups of patients with PSA more than10 ng/ml and age 
more than 70 years and when fewer fragments were collected by prostate 
biopsy puncture (6 vs. 10-12 cores). 
 
              Brock et al 
[18] 
(2012) analysed the detection of prostate cancer by 
real-time elastography guided biopsy in comparison to conventional systematic 
gray scale ultrasound guidance. They evaluated 353 patients who were 
suspicious for prostatic malignancy. Patients were randomized prospectively 
either for real time strain elastography (178) or conventional B-mode 
ultrasound (175). All patients underwent a 10-core prostate biopsy. Cancer 
suspicious areas detected by real time elastography and gray scale ultrasound 
were additionally targeted. On analysis they found that real-time elastography 
had a sensitivity and specificity of 60.8% and 68.4% respectively to detect 
prostate cancer whereas gray scale ultrasound had only a sensitivity and 
specificity of 15% and 92.3% respectively for cancer detection. 
 
              Gadalla et al 
[19] 
(2015) evaluated the diagnostic accuracy of 
ultrasound elastography for prostatic cancer detection and for differentiating 
benign from malignant conditions. They conducted study on 50 patients who 
  
 
 
were suspicious for malignancy and all these patients were subjected to 
transrectal grey scale ultrasound, color Doppler ultrasonography and real time 
ultrasound strain elastography in the same sitting. Results of these modalities 
were compared with histopathology. They found that elastography had a 
sensitivity of 74.2%, specificity of 73.7% and accuracy of 74.0% for prostate 
cancer detection. They concluded by stating that when elastography is 
combined with conventional ultrasound it can help to identify malignant lesions 
and thereby providing a mean to guide biopsy. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Observations and Results 
 
 
 
  
In this study, 30 patients with 
abnormal digital rectal examination
ultrasonography, transrectal
transrectal systematic 
abnormal areas detected by transrectal real time elastography
ultrasound and the findings of individual modalities were compared with the 
histopathological findings.
1. In the study population, 
(53%) were benign.
 
FIGURE 4 : DISTRIBUTION OF BENIGN AND MALIGNANT 
 
  
 
 
OBSERVATION AND RESULTS 
elevated prostate specific antigen level and 
 were evaluated with 
 real time strain Elastography and 
12-cores biopsy along with extra targeted biopsies from 
 
14 cases (47%) were malignant and 
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2. All the 14 malignant lesions were adenocarcinoma of prostate. 
3. Out of the 16 benign lesions, 10 (62.5%) were benign prostatic 
hyperplasia and 6 (37.5%) were prostatitis. 
 
TABLE 1 : DISTRIBUTION OF DIFFERENT TYPES OF BENIGN 
LESIONS 
 
TYPES OF BENIGN LESIONS 
 
 
FREQUENCY 
 
PERCENTAGE 
 
Benign Prostatic Hyperplasia 
 
 
10 
 
62.5 
 
Prostatitis 
 
 
6 
 
37.5 
 
TOTAL 
 
 
16 
 
100 
 
 
  
FIGURE 5 : DISTRIBUTION OF DIFFERENT TYPES OF BENIGN 
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TABLE 2 : AGE WISE DISTRIBUTION OF LESIONS 
 
 
AGE 
 
BENIGN 
 
MALIGNANT 
 
TOTAL 
NO OF 
CASES 
 
PERCENTAGE 
OF AGE 
DISTRIBUTION 
 
50 - 60 
 
4 
 
1 
 
5 
 
17 
 
60 - 70 
 
4 
 
3 
 
7 
 
23 
 
70 - 80 
 
7 
 
8 
 
15 
 
50 
 
80 - 90 
 
1 
 
2 
 
3 
 
10 
 
TOTAL 
 
16 
 
14 
 
30 
 
100 
 
 
 
 
  
 
 
 
 
FIGURE 7 : AGE WISE DISTRIBUTION OF BENIGN AND 
MALGNANT LESIONS 
 
 
 
In our study population, the mean age for malignancy was 72 years with a 
standard deviation of 8.8 and the mean age for benign lesions was 67 years 
with a standard deviation of 9.6. 
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TABLE 3 : DISTRIBUTION OF LESIONS BASED ON PSA LEVEL 
 
 
PSA 
(ng/mL) 
 
BENIGN 
 
MALIGNANT 
 
TOTAL 
NO OF 
CASES 
 
PERCENTAGE 
OF 
DISTRIBUTION 
 
<10 
 
11 
 
0 
 
11 
 
37 
 
10 - 20 
 
1 
 
4 
 
5 
 
17 
 
20 - 30 
 
1 
 
3 
 
4 
 
13 
 
>30 
 
3 
 
7 
 
10 
 
33 
 
TOTAL 
 
16 
 
14 
 
30 
 
100 
 
 
 
 
  
 
 
 
FIGURE 8 : DISTRIBUTION OF BENIGN AND MALGNANT LESIONS 
BASED ON PSA LEVEL 
 
 
 
In our study population, the mean PSA level for malignancy was 57ng/mL with 
a standard deviation of 40.6 and the mean PSA level for benign conditions was 
25.4ng/mL with a standard deviation of 37.2. 
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TABLE 4 : DISTRIBUTION OF LESIONS BASED ON PROSTATE 
SIZE 
 
 
PROSTATE 
SIZE 
(cm
3
) 
 
BENIGN 
 
MALIGNANT 
 
TOTAL 
NO OF 
CASES 
 
PERCENTAGE 
OF 
DISTRIBUTION 
 
<30 
 
6 
 
5 
 
11 
 
37 
 
30 – 40 
 
5 
 
5 
 
10 
 
33 
 
40 - 50 
 
1 
 
1 
 
2 
 
7 
 
>50 
 
4 
 
3 
 
7 
 
23 
 
TOTAL 
 
16 
 
14 
 
30 
 
100 
 
 
 
 
  
 
 
 
FIGURE 9 : DISTRIBUTION OF BENIGN AND MALGNANT LESIONS 
BASED ON PROSTATE SIZE 
 
 
 
 
In our study population, the mean size of prostate for malignancy was 38 cm
3
 
with a standard deviation of 19.9 and the mean size of prostate for benign 
conditions was also 38 cm
3
 with a standard deviation of 17.7. 
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TABLE 5 : DISTRIBUTION OF LESIONS BASED ON CLINICAL 
FINDINGS 
 
CLINICAL 
FINDINGS 
 
BENIGN 
 
MALIGNANT 
 
FREQUENCY 
 
PERCENTAGE 
OF CLINICAL 
FINDINGS 
 
Lower 
urinary tract 
symptoms 
 
13 
 
11 
 
24 
 
80 
 
Hematuria 
 
3 
 
3 
 
6 
 
20 
 
TOTAL 
 
16 
 
14 
 
30 
 
100 
 
Out of 30 patients, 24 presented with lower urinary tract symptoms like 
urgency, hesitation and incontinence. 13 cases turned out to be benign which 
included benign prostatic hyperplasia in 9 cases and prostatitis in 4 cases. 
Remaining 11 turned out to be adenocarcinoma of prostate. The next common 
complaint noted was hematuria. Out of 6 patients with complaints of hematuria 
3 were benign which includes 2 cases of prostatitis and 1 case of benign 
prostatic hypertrophy. Remaining 3 were proved as adenocarcinoma of 
prostate. 
  
FIGURE 10 (B) DISTRIBUTION OF LESIONS BASED ON THE 
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TABLE 6 : TRANSRECTAL ULTRASOUND FINDINGS IN 
CORRELATION WITH  HISTOPATHOLOGY 
 
 
TRUS FINDINGS 
 
HISTOPATHOLOGY 
 
BENIGN MALIGNANT 
 
POSTIVE FOR 
MALIGNANCY 
(n=14) 
 
3 
 
11 
 
NEGATIVE FOR 
MALIGNANCY 
(n=16) 
 
13 
 
3 
 
TOTAL 
 
16 
 
14 
 
On TRUS, features such as presence of hypoechoic lesions, hypervascular 
lesions, capsular irregularity were taken into account. Out of 30 cases, 14 
lesions suspicious of malignancy were identified on TRUS. Out of these 14 
cases, 11 were correctly identified as malignancy while 3 turned out to be 
benign lesions. TRUS failed to identify 3 malignant lesions. 
  
 
 
Statistical analysis: The chi square test (value of 10.7) for association 
between TRUS and HPE is found to be statistically significant (P value- 0.01) 
 
FIGURE 11 : TUMOR DETECTION RATE OF TRUS 
 
 
According to our study Transrectal ultrasound had sensitivity of 78.57%, 
specificity of 81.25 %, positive predictive value of 78.57 % and negative 
predictive value of 81.25 %. 
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lesions 
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TABLE 7 : DISTRIBUTION OF LESIONS ON THE BASIS OF 
ELASTOGRAPHIC GRADING 
 
 
ELASTOGRAPHY 
STRAIN 
 
NUMBER OF 
CASES 
 
PERCENTAGE 
OF 
DISTRIBUTION 
 
II 
 
8 
 
26 
 
III 
 
11 
 
37 
 
IV 
 
5 
 
17 
 
V 
 
6 
 
20 
 
TOTAL 
 
30 
 
100 
 
Of the 30 cases, 8 were classified under Elastography grade II, 11 under grade 
III, 5 under grade IV and 6 under grade V. 
 
  
FIGURE 12 : DISTRIBUTION OF LESIONS ON THE BASIS OF 
 
We used a elastography grading system proposed by kamoi et al 
study there were no lesions with grade I on elastography.
 
 
 
 
 
 
 
ELASTOGRAPHIC GRADING 
 
II
III
IV
V
 
[13]
 .In our 
  
 
 
Of the 30 cases, 8 lesions were classified under Elastography grade II. On 
histopathological evaluation, three was inflammatory lesions and five were 
proved as benign hypertrophy of prostate. No suspicious malignant features 
were detected on TRUS in these lesions. On Elastography these lesions showed 
symmetric heterogeneous strain. 
 
FIGURE 13 : HPE OF ELASTOGRAPHY GRADE II LESIONS 
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11 of the 30 lesions were categorized under Elastography grade III. On 
histopathology five of these lesions turned out to benign prostatic hyperplasia, 
three turned out to be inflammatory lesions and three tuned out to be 
adenocarcinoma of prostate. On transrectal ultrasound two of these lesions 
were suspicious for malignancy but on histopathology were proved as 
prostatitis and benign prostatic hyperplasia .All these lesions showed 
asymmetrical focal stiff lesion on elastography which was not related to any 
hypoechoic area on grey scale ultrasound. 
 
FIGURE 14 : HPE OF ELASTOGRAPHY GRADE III LESIONS 
 
 
 
 
0
1
2
3
4
5
6
7
8
9
Benign Malignant
Benign
Prostatic 
Hypertrophy
Prostatitis
8
3
  
5 lesions were categorized under Elastography grade I
the lesions were proved as adenocarcinoma of prostate. These lesions appear 
hypoechoic on transrectal ultrasound and showed 
strain at the periphery
 
FIGURE 15 : HPE OF ELASTOGRAPHY GRADE IV LESIONS
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Of the 30 cases included in the study, 
Elastography grade V. 
Histopathology. These lesions appear 
with stiffness in the entire lesion and in the surrounding area
 
FIGURE 16 : HPE OF ELASTOGRAPHY GRADE V LESIONS
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According to our study, Elastography has a sensitivity of 100 %, specificity of 
50%, positive predictive value of 63.64% and negative predictive value of 100 
%. 
 
TABLE 8 : ELASTOGRAPHY GRADE * HPE CROSS TABULATION 
 
 
ELASTOGRAPHY 
GRADE 
 
HISTOPATHOLOGY 
 
 
TOTAL  
BENIGN 
 
MALIGNANT 
I 0 0 0 
II 8 0 8 
III 8 3 11 
IV 0 5 5 
V 0 6 6 
 
TOTAL 
 
16 
 
14 
 
30 
 
 
Statistical analysis: The chi square test (value of 21.2) for association 
between Elastography and HPE is found to be statistically significant (P 
value –0.001). 
 
  
 
 
TABLE 9 : TRUS * ELASTOGRAPHY GRADE * HPE CROSS 
TABULATION 
 
 
 
HPE 
 
TRUS FINDINGS 
 
ELASTOGRAPHY 
GRADE 
 
POSITIVE 
 
NEGATIVE 
 
II 
 
III 
 
IV 
 
V 
 
Benign 
 
3 
 
13 
 
8 
 
8 
 
0 
 
0 
 
Malignant 
 
11 
 
3 
 
0 
 
3 
 
5 
 
6 
 
TABLE NO 10: DIAGNOSTIC EFFICACY OF TRUS AND 
ELASTOGRAPHY FOR DETECTING PROSTATE CANCER 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
 
POSITIVE 
PREDICTIVE 
VALUE (%) 
 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
TRUS 
 
78.57 
 
81.25 
 
78.57 
 
81.25 
 
Elastography 
 
100 
 
50 
 
63.64 
 
100 
 
  
 
 
              In our study population, 14 lesions were diagnosed to have 
malignancy with transrectal ultrasonography. Only 11 of the 14 lesions turned 
out to be malignant on Histopathology. On Elastography, 11 lesions had 
intermediate suspicion of malignancy (Grade III) out of which 3 turned to be 
malignant. Another 11 were strongly suspicious to be malignant on 
elastography (Grade IV and V) and all of them turned out to be 
adenocarcinoma of prostate. When we included only grade IV and V lesions on 
elastography as malignant, we found that elastography had a specificity and 
positive predictive value of 100%. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
  
 
 
DISCUSSION 
              In our prospective study 30 patients with elevated Prostate specific 
antigen level and abnormal digital rectal examination findings were evaluated 
with transrectal ultrasonography, transrectal real time strain elastography and 
were subjected to systematic 12-core biopsy with extra targeted biopsies from 
abnormal areas detected by transrectal real time elastography and transrectal 
ultrasound . The interpretation with each of the above mentioned modalities 
were compared with the Histopathological diagnosis. 
              In our study, the age of the patients ranged from 53 to 88 years. Most 
of the patients in our study were above the age of 60 years [25 patients (83%)]. 
This was found in correlation to findings observed by Jemal et al 
[20]
 that there 
will be a higher incidence of prostatic disease during old age. The mean age for 
malignancy according to our study was 72 years and the mean age for benign 
lesions was 67 years. 
              The most common clinical presentation of prostatic disease according 
to our study is lower urinary symptoms such as urgency, hesitation and 
increased frequency of micturation. In our series 24 patients (80%) presented 
with lower urinary tract symptoms of which 13 were diagnosed as benign 
diseases and 11 were diagnosed to have malignancy. The next common 
complaint was hematuria seen in 6 cases (20%), out of which 3 were benign 
and another 3 turned out to be malignant. 
  
 
 
              In the study population 16 (53%) lesions were benign and 14 (47%) 
lesions were malignant. All the malignant lesions were adenocarcinoma of 
prostate. Out of 16 benign lesions, 10 (62.5%) were benign prostatic 
hyperplasia and 6 (37.5%) were prostatitis. 
              In our study group PSA level were 4 ng/ml and above. Thompson et 
al. 
[21]
 and Schroder et al. 
[22]
 reported that in addition to cases of prostatic 
carcinoma, patients with benign prostatic hypertrophy and inflammatory 
conditions of prostate will also be presented with PSA level more than 4 ng/ml. 
According to our study the mean PSA level for malignancy was 57ng/mL and 
the mean PSA level for benign conditions was 25.4ng/mL. 
              The volume of the prostate gland in our study ranged from 8 to 89 
cm
3
, with a mean of 38.2 cm
3
. Seven patients (23%) in our study had high 
grade prostatomegaly which includes two patients with BPH (29%), two 
patient with prostatitis along with BPH (5%) and three patients with prostatic 
adenocarcinoma (43%), and their volumes ranged from 52 to 89 cm
3
. Chung et 
al. 
[23] 
reported that increased prostatic volume is a good indicator for prostate 
cancer even though it will be enlarged in both BPH and prostate cancer. 
              We used a 12-core systematic biopsy in all patients which was 
proposed by Levine et al. 
[4] 
.They showed an increased detection of prostate 
cancer by employing a 12-core biopsy when compared to standard sextant 
biopsy.  
  
 
 
              In our study, TRUS showed hypoechoic focal lesions in 14 patients 
(47%). On colour Doppler ultrasonography, 10 lesions (71.4%) showed 
increased vascularity and 4 lesions (28.5%) showed normal vascularity. Apple 
et al. 
[24] 
reported variable appearance of prostatic tumours in the ultrasound. 
TRUS alone will perform poorly for prostate cancer identification. Some 
tumours can be seen as hypoechoic areas which can be distinguished from 
normal homogenous parenchyma but most of the hypoechoic lesions are non 
cancerous. Also some tumors will be hyperechoic and many early stage cancers 
can be isoechoic which cannot be distinguished from surrounding normal 
tissue. According to our study TRUS had a positive predictive value of 78.57 
% and a negative predictive value of 81.25 %. Out of the 14 hypoechoic lesions 
identified on TRUS in our study, 11 lesions were proved as adenocarcinoma of 
prostate while 3 lesions turned out to be benign. TRUS failed to identify lesions 
in three patients. According to our study TRUS had sensitivity of 78.57 % and 
specificity of 81.25 % while in the study conducted by Terris et al. 
[25]
, TRUS 
had a sensitivity of 53.3% and a specificity of 75% only. 
              Of the 30 cases, eight cases were classified under Elastography grade 
II. In these patients prostate showed a symmetrical heterogeneous strain with 
no identifiable lesions on grey scale ultrasound. On histopathological analysis 
all these lesions turned out to be benign. 
In our study 11 lesions categorized under Elastography grade III. In 
these patients there was a focal asymmetric stiff lesion identified on 
elastography which was not related to any hypoechoic area on grey scale 
  
 
 
ultrasound. 8 (73%) of these lesions were benign and 3 (27%) were malignant 
on histopathology.  
              In our study 5 lesions were categorized under grade IV on 
elastography. These lesions appeared as hypoechoic lesions on ultrasound and 
showed stiffness in the center of the lesion and strain at the periphery. All these 
lesions turned out to be malignant on histopathology. 
              In our study 6 lesions were categorized under elastography grade V. 
They appeared hypoechoic on grey scale and showed stiffness in the entire 
hypoechoic lesion and in the surrounding area. All of these lesions also turned 
to be malignant on histopathology.  
              We used elastograhic approach described by Kamoi et al. 
[13]
 .In our 
study on 30 men, 8 did not show suspicious findings on elastography which 
represent 27% of the study population. This was correlating to the study done 
by Aigner et al. 
[16]
 .In their study only 3 out of 43 patients who had normal 
elastography turned to be malignant, but in our study all cases with normal 
elastography were benign. 
              Of the 22 patients with suspicious elastography findings, 14 were 
diagnosed to have cancer. False-positive findings were noted in 8 cases on real 
time elastography. All these lesions were graded as III on elastography with 
intermediate suspicion of malignancy but on histopathology 5 of them were 
BPH and 3 were prostatitis. Positive predictive value of elastography according 
to our study was 63.64% which was more compared to the study done by 
  
 
 
Aigner et al 
[16]
 (39%). All the lesions with Grade IV and V on elastography 
turned to be malignant. Our study showed high sensitivity and negative 
prediction value for elastography. This was comparable to the results observed 
by Aigner et al 
[16]
, which had a sensitivity of 74% and Negative prediction 
value of 93%. We also observed that if lesions with higher grades on 
elastography (Grade IV and V) only were taken as malignant, the specificity 
and positive predictive value of elastography can be increased to 100%. Based 
on a small number of cases our data suggest that Real time elastography was 
more sensitive and had a higher negative predictive value than TRUS in 
prostate cancer identification. Hence we infer Elastography can be used 
effectively to increase the confidence level to rule out malignancy and hence 
avoid unnecessary biopsies. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary 
 
  
 
 
SUMMARY 
              This was a prospective study on prostate cancer detection in 30 
patients with transrectal real time ultrasonography and transrectal real time 
elastography for identification of malignancy in suspicious patients and the 
interpretation from the individual modalities were compared with 
Histopathology. Benign lesions accounted for 53% of the patients and 
malignant lesions for 43%. 
              The benign lesions in our study were Benign Prostatic Hyperplasia 
(62.5%) and prostatitis (37.5%). All the malignant lesions in our study turned 
to be adenocarcinoma of prostate. 
              The study group included male patients of more than 50 years, with 
majority of the malignant lesions being found in the age group between 70 and 
80 yrs, accounting for 57 % of the malignancies.  
              In TRUS, hypoechoic lesions with increased vascularity were good 
predictors of malignancy. All the malignant lesions identified by TRUS 
appeared hypoechoic on grey scale with increased vascularity on colour 
doppler. 21% of the hypoechoic lesions by TRUS were found to be benign. 
TRUS was not able to detect any lesions in 21% of cases which were positive 
for malignancy. TRUS has a sensitivity of 78.57 %, specificity of 81.25 %, 
positive predictive value of 78.57 % and negative predictive value of 81.25% 
for identifying prostatic carcinoma. 
  
 
 
              On Elastography, 8 cases were graded as normal and 22 cases were 
graded suspicious for malignancy. All the elastography normal cases were 
proved as benign conditions while out of 22 cases suspicious for malignancy, 
only 14 were positive for cancer. All the false positive cases were categorized 
as grade III on elastography. None of the lesions with higher grades on 
elastography (Grade IV and V) were benign. Elastography had a sensitivity of 
100 %, specificity of 50%, positive predictive value of 63.64% and negative 
predictive value of 100 % for prostate cancer detection according to our study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 
 
  
 
 
CONCLUSION 
 
1. Transrectal ultrasound is helpful in identifying malignant lesions of 
prostate. 
2. Hypoechoic lesions with increased vascularity are sensitive predictors of 
malignancy. 
3. Transrectal ultrasound had a sensitivity of 78.57 %, specificity of 81.25 
%, positive predictive value of 78.57 % and negative predictive value of 
81.25 % for prostate cancer detection. 
4. Elastography had a sensitivity of 100 %, specificity of 50%, positive 
predictive value of 63.64% and negative predictive value of 100 % for 
prostate cancer detection. 
5. Specificity of elastography can be increased to 100% when Grade IV 
and V lesions only are taken as malignant. 
6. Elastography has increased sensitivity and high negative predictive 
value for ruling out malignancies when compared to ultrasound and 
helps to avoid unnecessary biopsies. 
7. Combined use of elastography along with ultrasound helps to identify 
malignant lesions and provides a means to guide biopsies thereby 
increasing the cancer detection rate. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recommendations 
 
  
 
 
 
RECOMMENDATIONS 
 
• We would propose to use Elastography as a complimentary tool to 
Transrectal Ultrasound for prostate cancer detection. 
• Elastographic characterization of a lesion should be made after 
analyzing the B-mode characteristics of the lesion. 
• Experience is needed to obtain reproducible results as the acquisition 
of images and the quality of the images produced are dependent on 
the operator. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Limitations 
 
 
  
 
 
 
LIMITATIONS OF ULTRASOUND ELASTOGRAPHY 
 
 
• Operator dependant. 
• Non uniform compression. 
• Lack of penetration in large prostate glands. 
• Artifacts due compression plane slippage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative Cases 
 
 
  
 
 
REPRESENTATIVE CASES 
Case 1 
A 57 year old male patient with lower urinary tract symptoms. 
FIGURE 17 (A)  
 
 
On transrectal B-mode ultrasonography, the prostate was enlarged in size and 
shows uniform echogenicity with no demonstrable lesions. 
 
 
 
  
 
 
 
FIGURE 17 (B) 
 
 
On colour Doppler ultrasonography, the prostate shows normal symmetrical 
vascularity. 
 
 
 
 
 
  
 
 
 
 
FIGURE 17 (C) 
 
 
On elastography the prostate gland shows symmetric heterogeneous strain 
(mosaic and symmetrical pattern of blue and green). Elastography Grade II. 
 
HISTOPATHOLOGY: Benign Nodular Hyperplasia. 
 
 
  
 
 
 
Case 2 
A 75 year old male patient with complaints of hematuria. 
FIGURE 18 (A) 
 
 
On transrectal ultrasonography, the prostate was enlarged in size and shows 
heterogeneous echogenicity with normal symmetrical vascularity on colour 
Doppler. 
 
 
  
 
 
 
 
FIGURE 18 (B) 
 
 
On elastography the prostate gland shows a focal asymmetric stiff lesion in 
right lobe which was not related to any hypoechoic area on transrectal 
ultrasonography (the focal asymmetric lesion in blue).  
Elastography Grade III. 
HISTOPATHOLOGY: Acute prostatitis. 
 
  
 
 
Case 3: 
A 74 year old male patient with lower urinary tract symptoms. 
 
FIGURE 19 (A) 
 
 
On transrectal B-mode ultrasonography, the prostate was enlarged in size and 
shows heterogeneous echogenicity with few hypoechoic lesions in bilateral 
peripheral zones. 
 
 
  
 
 
 
FIGURE 19 (B) 
 
 
On colour Doppler ultrasonography, the lesions in peripheral zones showed 
increased vascularity. 
 
 
 
 
 
  
 
 
 
FIGURE 19 (C) 
 
 
On elastography the hypoechoic lesions shows stiffness in the center of the 
lesion and strain at the periphery (periphery of the lesion in green and the 
central part in blue). Elastography Grade IV. 
 
HISTOPATHOLOGY: Prostatic adenocarcinoma. Gleason's score – 7. 
 
 
 
  
 
 
Case 4 
A 72 year old male patient with lower urinary tract symptoms. 
FIGURE 20 (A) 
 
 
 
On transrectal ultrasonography, the prostate was enlarged in size and shows 
heterogeneous echogenicity with a hypoechoic lesion in right peripheral zone. 
On colour Doppler ultrasonography, the lesion showed increased vascularity. 
 
 
 
  
 
 
FIGURE 20 (B) 
 
On elastography the hypoechoic lesion and surrounding area showed increased 
stiffness (the entire lesion and surrounding area appeared blue). Elastography 
Grade V 
 
HISTOPATHOLOGY: Prostatic adenocarcinoma. Gleason's score -6 
 
 
 
 
  
 
 
 
Case 5 
A 87 year old male patient with lower urinary tract symptoms. 
FIGURE 21 (A) 
 
 
On transrectal B-mode ultrasonography, the prostate was grossly enlarged in 
size and shows heterogeneous echogenicity with few hypoechoic lesions in 
bilateral peripheral zones. 
 
 
  
 
 
 
FIGURE 21 (B) 
 
 
On colour Doppler ultrasonography, the lesions in peripheral zones showed 
increased vascularity. 
 
 
 
 
 
  
 
 
 
FIGURE 21 (C) 
 
 
On elastography there was stiffness in the entire hypoechoic lesion in the right 
lobe and in the surrounding area (the entire lesion and surrounding area in 
blue). Elastography Grade V 
 
HISTOPATHOLOGY: Prostatic adenocarcinoma. Gleason's score -9 
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Annexures 
 
 
 
  
 
 
LIST OF ABBREVIATIONS: 
 
BPH   : BENIGN PROSTATIC HYPERPLASIA 
 
CT      : COMPUTED TOMOGRAPHY 
 
DRE   : DIGITAL RECTAL EXAMINATION 
 
HPE    : HISTOPATHOLOGICAL EXAMINATION 
 
INR    : INTERNATIONAL NORMALISED RATIO 
 
MRI    : MAGNETIC RESONANCE IMAGING 
 
PSA    : PROSTATE SPECIFIC ANTIGEN 
 
ROI    : REGION OF INTEREST 
 
TRUS : TRANSRECTAL ULTRASONOGRAPHY 
 
TURP : TRANSURETHRAL RESECTION OF PROSTATE 
 
USG   : ULTRASONOGRAPHY 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Master Chart 
 
  
 
 
H
P
E
 F
in
d
in
g
s 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 6
 
(3
+
3
) 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 7
  
 
(4
+
3
) 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
E
la
st
o
g
ra
p
h
ic
 
g
ra
d
e 
V
 
II
I 
II
 
II
I 
V
 
II
I 
T
R
U
S
 F
in
d
in
g
s 
H
y
p
o
ec
h
o
ic
 l
es
io
n
s 
in
 b
il
at
er
al
 
p
er
ip
h
er
al
 z
o
n
es
 w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 l
ef
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 n
o
rm
al
 
sy
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
s 
in
 b
il
at
er
al
 
p
er
ip
h
er
al
 z
o
n
es
 w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
P
ro
st
a
te
 
V
o
lu
m
e 
3
0
 
3
6
 
3
0
 
2
5
 
3
9
 
1
0
 
P
S
A
 
L
ev
el
 
6
8
.2
 
5
.2
 
4
.8
 
3
.9
9
 
>
1
0
0
.0
 
1
3
.8
 
C
li
n
ic
a
l 
F
in
d
in
g
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
H
o
sp
it
a
l 
ID
 
O
1
5
0
2
5
4
3
7
 
O
1
5
0
3
0
3
7
9
 
O
9
9
0
2
1
7
5
2
 
O
1
5
0
3
9
6
0
5
 
O
1
5
0
3
5
9
0
1
 
O
1
5
0
4
0
7
1
1
 
A
g
e 
7
0
 
7
5
 
7
6
 
5
7
 
6
5
 
7
6
 
N
a
m
e 
P
al
an
is
am
y
 
M
u
th
u
sa
m
y
 
G
u
n
al
an
 
S
el
v
ar
at
h
in
am
 
A
ru
m
u
g
am
 
D
am
o
d
ar
sa
m
y
 
S
. 
N
o
 
1
 
2
 
3
 
4
 
5
 
6
 
  
 
 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
A
cu
te
 p
ro
st
at
it
is
 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
  
7
 
(3
+
4
) 
A
cu
te
 p
ro
st
at
it
is
 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 7
 
(4
+
3
) 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
II
 
II
I 
II
I 
II
I 
IV
 
II
 
II
I 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
et
er
o
g
en
eo
u
s 
ec
h
o
g
en
ic
it
y
 
w
it
h
 n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 r
ig
h
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 n
o
rm
al
 
sy
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 r
ig
h
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
2
6
 
3
9
 
4
3
 
2
6
 
6
1
 
5
2
 
6
0
 
5
.1
 
>
1
0
0
.0
 
1
0
.8
 
8
.4
 
>
1
0
0
.0
 
8
.1
 
9
.1
 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
H
em
at
u
ri
a 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
O
1
5
0
4
5
6
7
0
 
O
1
5
0
5
3
7
7
8
 
O
1
0
0
8
3
0
7
7
 
O
1
5
0
6
6
9
6
2
 
O
1
5
0
7
1
1
7
2
 
O
1
5
0
7
5
1
9
6
 
O
1
3
0
3
0
5
3
8
 
7
3
 
6
2
 
7
7
 
7
2
 
7
6
 
6
3
 
7
0
 
F
o
n
i 
u
sh
an
 
Ja
g
an
at
h
an
 
K
an
ag
ar
aj
 
T
h
an
g
av
el
 
P
al
an
ia
p
p
an
 
S
h
an
m
u
g
am
 
L
ak
sh
m
an
an
 
7
 
8
 
9
 
1
0
 
1
1
 
1
2
 
1
3
 
  
 
 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 9
 
(4
+
5
) 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 7
 
(3
+
4
) 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 7
 
(4
+
3
) 
A
cu
te
 p
ro
st
at
it
is
 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
A
cu
te
 p
ro
st
at
it
is
 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 9
 
(4
+
5
) 
II
I 
IV
 
IV
 
II
I 
II
 
II
 
V
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
as
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
s 
in
 b
il
at
er
al
 
p
er
ip
h
er
al
 z
o
n
es
 w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
s 
in
 b
il
at
er
al
 
p
er
ip
h
er
al
 z
o
n
es
 w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
H
et
er
o
g
en
eo
u
s 
ec
h
o
g
en
ic
it
y
 
w
it
h
 n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
as
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 r
ig
h
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
2
7
 
3
3
 
2
7
 
2
4
 
3
1
 
6
5
 
2
7
 
2
8
.4
 
2
4
.4
 
1
4
.4
 
5
.3
 
4
.3
 
8
 
1
7
.8
 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
H
em
at
u
ri
a 
H
em
at
u
ri
a 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
O
1
5
0
8
3
8
2
2
 
O
1
5
0
8
4
5
2
9
 
O
1
5
0
8
6
6
1
0
 
O
1
5
0
8
4
5
6
7
 
O
1
6
0
0
2
8
3
9
 
O
1
5
0
2
9
4
3
5
 
O
1
6
0
0
8
4
5
8
 
6
6
 
7
0
 
7
4
 
7
5
 
5
3
 
6
2
 
7
7
 
M
an
th
ri
y
ap
p
an
 
R
aj
 
Jo
se
p
h
 
T
h
an
ik
ac
h
al
am
 
M
ek
so
n
 M
an
i 
B
h
ee
m
an
 
A
th
m
al
in
g
am
 
1
4
 
1
5
 
1
6
 
1
7
 
1
8
 
1
9
 
2
0
 
  
 
 
A
cu
te
 p
ro
st
at
it
is
 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
 7
 
(3
+
4
) 
A
cu
te
 p
ro
st
at
it
is
 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
9
 
(4
+
5
) 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
6
 
(3
+
3
) 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
8
 
(4
+
4
) 
II
 
II
I 
II
 
V
 
II
I 
V
 
IV
 
H
et
er
o
g
en
eo
u
s 
ec
h
o
g
en
ic
it
y
 
w
it
h
 n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
et
er
o
g
en
eo
u
s 
ec
h
o
g
en
ic
it
y
 
w
it
h
 n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
s 
in
 b
il
at
er
al
 
p
er
ip
h
er
al
 z
o
n
es
 w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 r
ig
h
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 r
ig
h
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 l
ef
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 i
n
cr
ea
se
d
 
v
as
cu
la
ri
ty
 
7
8
 
8
 
2
8
 
5
6
 
4
5
 
3
8
 
2
0
 
9
.2
 
>
1
0
0
.0
 
2
2
.5
 
>
1
0
0
.0
 
>
1
0
0
.0
 
>
1
0
0
.0
 
>
1
0
0
.0
 
H
em
at
u
ri
a 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
H
em
at
u
ri
a 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
H
em
at
u
ri
a 
O
1
5
0
7
9
7
7
0
 
O
0
9
1
0
4
2
0
0
 
O
1
5
0
8
0
4
8
8
 
O
1
6
0
3
6
2
0
3
 
O
1
6
0
4
0
6
8
2
 
O
1
5
0
0
6
9
7
2
 
O
9
6
0
0
2
2
7
1
 
8
6
 
5
4
 
5
3
 
6
5
 
6
3
 
7
2
 
8
8
 
R
am
al
in
g
am
 
G
an
es
h
an
 
R
aj
en
d
ra
n
 
N
ag
ar
aj
an
 
M
an
ic
k
am
 
P
al
an
is
am
y
 
K
ri
sh
n
as
am
y
 
2
1
 
2
2
 
2
3
 
2
4
 
2
5
 
2
6
 
2
7
 
  
 
 
B
en
ig
n
  
N
o
d
u
la
r 
 
H
y
p
er
p
la
si
a 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
6
 (
3
+
3
) 
P
ro
st
at
ic
  
ad
en
o
ca
rc
in
o
m
a.
 
G
le
as
o
n
's
  
sc
o
re
 -
9
 (
5
+
4
) 
II
 
IV
 
V
 
U
n
if
o
rm
 e
ch
o
g
en
ic
it
y
 w
it
h
 
n
o
rm
al
 s
y
m
m
et
ri
ca
l 
v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
 i
n
 r
ig
h
t 
p
er
ip
h
er
al
 z
o
n
e 
w
it
h
 
in
cr
ea
se
d
 v
as
cu
la
ri
ty
 
H
y
p
o
ec
h
o
ic
 l
es
io
n
s 
in
 
b
il
at
er
al
 p
er
ip
h
er
al
 z
o
n
es
 
w
it
h
 i
n
cr
ea
se
d
 v
as
cu
la
ri
ty
 
3
7
 
3
7
 
8
9
 
>
1
0
0
.0
 
2
1
 
1
6
.7
 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
L
o
w
er
 u
ri
n
ar
y
 
tr
ac
t 
sy
m
p
to
m
s 
O
0
7
0
8
2
4
2
4
 
O
1
6
0
5
7
4
3
2
 
O
1
1
0
4
1
8
1
9
 
5
7
 
7
0
 
8
7
 
R
am
am
u
rt
h
y
 
D
h
an
d
ap
an
i 
D
h
am
o
d
ar
an
 
2
8
 
2
9
 
3
0
 
 
